Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age

BACKGROUND: To determine the effectiveness of intravitreal ranibizumab (IVR) approach over 1-year follow-up in patients younger than 50 years old with central and branch retinal vein occlusion (RVO) complicated by macular edema (ME). METHODS: Prospective, open-label case series. Patients initiating...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomed Res Int
Egile Nagusiak: Battaglia Parodi, Maurizio, Romano, Francesco, Arrigo, Alessandro, Mercuri, Stefano, Franceschi, Alessandro, Bandello, Francesco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320288/
https://ncbi.nlm.nih.gov/pubmed/32685489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4747696
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak